AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 74(6), 2006, pp. 1020-1025
Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SUZUKI, T.
Right arrow Articles by SUZUKI, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SUZUKI, T.
Right arrow Articles by SUZUKI, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Trypanosomiasis

BENEFICIAL EFFECT OF ERYTHROPOIETIN ADMINISTRATION ON MURINE INFECTION WITH TRYPANOSOMA CONGOLENSE

TOMOKO SUZUKI, YOSHIKO YANAGIMOTO UETA, NOBORU INOUE, XUENAN XUAN, HIDEKI SAITOH, AND HIROSHI SUZUKI*
Research Unit for Functional Genomics, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan; Department of Developmental and Medical Technology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

The effect of erythropoietin treatment on Trypanosoma congolense infection in mice was studied. Survival rates of mice were dramatically improved by treatment with recombinant human erythropoietin (r-hu-EPO; 5000 U/kg) when infected with 1,000 cells of T. congolense IL3000 (P < 0.05). All the untreated mice infected with T. congolense IL3000 died by day 9 of infection; however, 100%, 50%, and 25% of the mice treated with r-hu-EPO for 8 days survived to day 20, day 40, and day 60 of the parasitical infection, respectively. Anti-8-hydroxy-2'-deoxyguanosine antibody, a biomarker for oxidative damage of DNA, yielded positive reactions in the cytoplasm of the parasites recovered from the mice treated with r-hu-EPO. These results, taken together, indicate that erythropoietin administration is effective for the treatment of T. congolense infection.

Received October 14, 2005. Accepted for publication February 14, 2006.

Acknowledgments: The authors thank S. Fukumoto and M. Okamura for technical assistance. Pacific Edit reviewed the manuscript before submission.

Financial support: This study was supported, in part, by a grant from Special Coordination Fund for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science, Japan.

* Address correspondence to Hiroshi Suzuki, Research Unit for Functional Genomics, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Nishi z-13, Inada, Obihiro, Hokkaido 080-8555, Japan. E-mail: hisuzuki{at}obihiro.ac.jp

Authors’ addresses: Tomoko Suzuki, Yoshiko Yanagimoto Ueta, Noboru Inoue, Xuenan Xuan, and Hiroshi Suzuki, Research Unit for Functional Genomics, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Nishi 2-13, Inada, Obihiro, Hokkaido 080-8555, Japan. Hideki Saitoh, Chugai Pharmaceutical Co., Ltd., Kyobashi, Chiyoda-ku, Tokyo, Japan. Hiroshi Suzuki, Department of Developmental and Medical Technology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan, E-mail: hisuzuki{at}obihiro.ac.jp.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Tropical Medicine and Hygiene.